Stay updated with breaking news from Jo Varshney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Earlier this week, Charles River Laboratories International, Inc. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.
In an overwhelming response to the news that SimBioSys and General Inception had joined forces to use advanced AI and biophysical modeling, to gain deeper insights into tumor biology, the industry has spoken.
VeriSIM Life, a health care technology company, utilizes AI to forecast drug candidates' clinical success, accelerating development and reducing costs. Founder and CEO, Jo Varshney, discusses successful applications, challenges, privacy standards, and advice for leveraging AI in health care operations.
Jo Varshney, DVM, PhD, the founder of VeriSIM Life, shares her journey to her current position and the role of courage in it.
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials LONDON, Dec. 5, 2023 /CNW/ -- Clarivate Plc